receptor is a ligandgated cation channel that is highly expressed on monocyte-macrophages and that mediates the pro-inflammatory effects of extracellular ATP. Dilation of the P2X7 channel and massive K ϩ efflux follows initial channel opening, but the mechanism of secondary pore formation is unclear. The proteins associated with P2X7 were isolated by using anti-P2X7 monoclonal antibody-coated Dynabeads from both interferon-␥ plus LPS-stimulated monocytic THP-1 cells and P2X7-transfected HEK-293 cells. Two nonmuscle myosins, NMMHC-IIA and myosin Va, were found to associate with P2X7 in THP-1 cells and HEK-293 cells, respectively. Activation of the P2X7 receptor by ATP caused dissociation of P2X7 from nonmuscle myosin in both cell types. The interaction of P2X7 and NMMHC-IIA molecules was confirmed by fluorescent life time measurements and fluorescent resonance of energy transfer-based time-resolved flow cytometry assay. Reducing the expression of NMMHC-IIA or myosin Va by small interfering RNA or short hairpin RNA led to a significant increase of P2X7 pore function without any increase in surface expression or ion channel function of P2X7 receptors. S-l-blebbistatin, a specific inhibitor of NMMHC-IIA ATPase, inhibited both ATPinduced ethidium uptake and ATP-induced dissociation of P2X7-NMMHC-IIA complex. In both cell types nonmuscle myosin closely interacts with P2X7 and is dissociated from the complex by extracellular ATP. Dissociation of this anchoring protein may be required for the transition of P2X7 channel to a pore. short hairpin RNA; blebbistatin; THP-1 cells; fluorescent resonance energy transfer; ethidium uptake; myosin IIA; myosin Va; phagocytosis THE P2X7 RECEPTOR is a ligand-gated cation channel highly expressed on monocytes and macrophages that mediates the pro-inflammatory effects of extracellular ATP (23, 27, 41). The P2X 7 receptor has two transmembrane domains with intracellular amino and carboxyl termini and an extracellular domain containing several ␤-pleated sheets within a tertiary structure maintained by five disulfide bonds (43). Activation of the receptor by brief exposure to extracellular ATP opens a cationselective channel, whereas longer exposure to ATP leads to secondary pore formation and massive K ϩ efflux, which is a costimulus for secretion of pro-inflammatory cytokines 31) . Other downstream effects of P2X 7 activation include blebbing of the plasma membrane (49), shedding of surface L-selectin and CD23 (17), rapid secretion of matrix metalloproteinase-9 (18), and activation of the caspase cascade leading to a form of apoptotic cell death (8, 14) . P2X 7 has been shown to exist as a trimer within a large multimolecular complex in the membrane (29). Moreover, activation of P2X 7 mediates actin reorganization and membrane blebbing in mouse macrophages (33, 50, 51), suggesting some functional connections between the P2X 7 receptor and the actin cytoskeleton.
short hairpin RNA; blebbistatin; THP-1 cells; fluorescent resonance energy transfer; ethidium uptake; myosin IIA; myosin Va; phagocytosis THE P2X7 RECEPTOR is a ligand-gated cation channel highly expressed on monocytes and macrophages that mediates the pro-inflammatory effects of extracellular ATP (23, 27, 41) . The P2X 7 receptor has two transmembrane domains with intracellular amino and carboxyl termini and an extracellular domain containing several ␤-pleated sheets within a tertiary structure maintained by five disulfide bonds (43) . Activation of the receptor by brief exposure to extracellular ATP opens a cationselective channel, whereas longer exposure to ATP leads to secondary pore formation and massive K ϩ efflux, which is a costimulus for secretion of pro-inflammatory cytokines IL-1␤ and IL-18 (13, 31) . Other downstream effects of P2X 7 activation include blebbing of the plasma membrane (49) , shedding of surface L-selectin and CD23 (17) , rapid secretion of matrix metalloproteinase-9 (18) , and activation of the caspase cascade leading to a form of apoptotic cell death (8, 14) . P2X 7 has been shown to exist as a trimer within a large multimolecular complex in the membrane (29) . Moreover, activation of P2X 7 mediates actin reorganization and membrane blebbing in mouse macrophages (33, 50, 51) , suggesting some functional connections between the P2X 7 receptor and the actin cytoskeleton.
The myosin family, which consists of at least 20 structurally and functionally distinct classes, constitutes the major component of the cytoskeleton. Nonmuscle myosins are able to convert the energy of ATP hydrolysis into vectorial movement of organelles or cargo along actin filaments, although some nonmuscle myosins also have anchoring or tethering function for membrane molecules (9, 25) . Nonmuscle myosin heavy chains usually consist of three distinct regions: one or two NH 2 -terminal heads (or motors) that are responsible for actin binding and ATP hydrolysis; a neck region called light-chain binding domain that binds calmodulin-like regulatory light chain and essential light chain; and a long COOH-terminal tail that is responsible for cargo binding and/or dimerization of heavy chains (25) . In nonmuscle cells, myosin II, as well as myosin V, are the two best characterized members of the myosin superfamily, and both are essential for viability in early life (7, 28) . Myosin II has at least three isoforms: IIA, IIB, and IIC. Nonmuscle myosin IIA heavy chain (NMMHC-IIA) is present in almost all nonmuscle cells (39) and associated with membrane (9) involving preservation of cell morphology (53) and motility (21, 44) , membrane repair (46) , neuroblastoma cell adhesion and retraction (55, 56) , as well as vesicle transport (9) such as MHC class II trafficking and B cell receptordriven antigen presentation (48) . It is also essential for maintaining cell-cell adhesions in the early mammalian embryo (7) . Mutations in MYH9, the gene encoding NMMHC-IIA, have been associated with May-Hegglin anomaly characterized by large platelets, thrombocytopenia, and neutrophil inclusions (38) . NMMHC-IIA has also been shown to associate with many membrane proteins: It binds COOH-terminus of CXCR4 and CCR5 (36) and has been implicated in the endocytosis of CXCR4 via dynamic association with ␤-arrestin (35) . NMMHC-IIA also binds a plasma-membrane-associated protein supervillin, which is involved in cell spreading (44) . S-l-blebbistatin (S-bleb) is a specific inhibitor for the ATPase of NMMHC-IIA and IIB and rapidly and reversibly inhibits NMMHC-II-mediated cell blebbing during cytokinesis (42) . This inhibitor has also been shown to prevent the dissociation of NMMHC-IIA from CD38, a membrane protein on activated killer cells thus inhibiting IL8-stimulated CD38 internalization (34) . Like myosin II, myosin V also has three isomers, Va, Vb, and Vc. Myosin Va, also known as nonmuscle myosin heavy chain 12, is primarily expressed in neurones of the central nervous system and melanocytes and functions in rapid transport of various cargos in these cells (10) .
There are few studies of the proteins associated with P2X 7 in the cell membrane. In transfected HEK-293 cells, P2X 7 has been reported in a membrane complex, which included laminin-␣ 3 chain, ␤ 2 -integrin, protein tyrosine phosphatase-␤, ␤-actin, ␣-actinin 4, heat shock 71-kDa protein, heat shock 70-kDa protein 1, heat shock protein 90-␤, phosphatidylinositol 4 kinase, membrane-associated guanylate kinase (MAGUK) P55, and supervillin (24) . In transfected cervical endothelial cells, P2X 7 has also been associated with a G protein-coupled receptor kinase (GRK-3), ␤-arrestin-2, dynamin, and clathrin (12) . In mouse native lung epithelial cells, P2X 7 has also been shown to bind with caveolin-1 present in lipid rafts (4) . In this study, we isolated P2X 7 -associated proteins with anti-P2X 7 monoclonal (L4)-coated Dynabeads using as a source of cells either interferon-stimulated human monocytic THP-1 cells or P2X 7 transfected HEK-293 cells. In both cell types nonmuscle myosin was found in the P2X 7 membrane complex as well as other proteins of the cytoskeleton, although the nonmuscle myosin was of different class in monocytes and HEK-293 cells. In both cell types, ATP dissociated nonmuscle myosin from the P2X 7 complex, an event that was associated with P2X 7 channel to pore transition.
EXPERIMENTAL PROCEDURES
Materials. ATP, BzATP, oxidized ATP (OxATP), phorbol 12-myristate 13-acetate (PMA), ML-7, ethidium bromide, sodium chloride, potassium chloride, barium chloride, D-glucose, bovine serum albumin (BSA), EDTA, tetramethylammonium hydroxide (TMA), lipopolysaccharides (LPS), ε-amino-n-caproic acid, n-dodecyl ␤-Dmaltoside, proteose peptone, and Triton X-100 were purchased from Sigma (St. Louis, MO). Ficoll-Paque Plus and the GFX PCR DNA and Gel Band Purification Kit were from GE Healthcare (Uppsala, Sweden). 1-(N,O-bis(5-isoquinoline sulfonyl) N-methyl-L-tyrosyl)-4-phenylpiperazine (KN-62) was from R&D System (Minneapolis, MN). The recombinant human interferon-␥ (IFN␥), minicomplete protease inhibitor cocktail, phenylmethylsulfonyl fluoride (PMSF) plus were from Roche Applied Science (Mannheim, Germany). ATP was dissolved in KCl buffer (in mM: 145 KCl, 5 KCl, and 10 HEPES, pH 7.5) at a stock concentration of 100 mM and neutralized with 18% (wt/vol) TMA to pH 7.4. HEPES, fetal calf serum (FCS), normal horse serum, Lipofectamine 2000 reagent, Opti-MEM I medium, Taq DNA polymerase, One-step RT-PCR kit for long template, vector pcDNA3, M-280 tosylactivated Dynabeads were from Invitrogen (Carlsbad, CA). Vector pEGFP-N1, pEGFP-C1, pAcGFP-N1 and pDsRed-monomer-N1 were from Clontech (Mountain View, CA). Wild-type P2RX7 construct was originally a gift from Dr. Gary Buell and was reconstructed into the above vectors in our lab. Rabbit anti-human NMMHC antibody was from Biomedical Technologies (Stoughton, MA). Rabbit anti-myosin Va antibody was from Santa Cruz (Santa Cruz, CA). Mouse anti-human NMMHC-IIA mAb, goat anti-human Ro-52 (SSA) polyclonal Ab, and anti-␤-actin loading control Ab were from Abcam (Cambridge, UK). Mattek culture dishes with collagen-coated 1.0-mm slides were from Mattek (Ashland, MA). (S)-l-blebbistatin (S-bleb) and its inactive isomer (R)-d-blebbistatin (R-bleb) were from Toronto Research Chemicals (North York, Canada). Oligos [primers and small interfering RNA (siRNA)] were synthesized locally by Sigma-Proligo. Mission short hairpin RNA (shRNA) for human nonmuscle myosin heavy chain IIA or myosin Va were purchased from Sigma-Genosis. Restriction enzymes were from New England Biolabs (Beverly, MA). Fluorescein (FITC), phycoerythrin (PE), PE-Cy5-conjugated anti-CD mAb, and horseradish peroxidase-conjugated rabbit anti-sheep and anti-rabbit immunoglobulin antibody were from Dako (Glostrup, Denmark). Murine anti-human P2X 7 receptor mAb (clone L4, kindly provided by Drs. Gary Buell and Ian Chessell) (5) and IgG2b isotype control mAb (clone WMD7, from the Millennium Institute, Westmead, NSW, Australia) were purified from clone hybridoma supernatants by chromatography on Protein A Sepharose Fast Flow as described previously (19) . Sheep anti-human P2X 7 polyclonal antibody was raised against a nonhomologous extracellular epitope of the human P2X 7 receptor as described previously (54) . Rabbit anti-rat P2X7 polyclonal antibody cross-reacting with human P2X 7 has also been described previously (40) . The SuperSignal West Pico Chemiluminescent Substrate kit was from Pierce Endogen (Rockford, IL). The HEKfectin, precast 4 -20% gradient mini-gels, and prestained precise protein marker were from Bio-Rad (Hercules, CA).
Sources of cells. Human peripheral blood mononuclear cells were separated by density gradient centrifugation over Ficoll-Hypaque, washed once in RPMI-1640 medium, and resuspended in HEPESbuffered NaCl medium (in mM: 140 NaCl, 5 NaOH, 5 KCl, and 10 HEPES, pH 7.5, plus 5 mM glucose, 0.1% BSA, and 0.1 mM CaCl 2). Human monocytic cell line THP-1 and human embryonic kidney cell line HEK-293 were cultured in RPMI-1640 medium containing 10% fetal calf serum and 5 g/ml gentamycin. To differentiate THP-1 to macrophage-like cells, cells (0.5 ϫ 10 6 /ml) were incubated with 1,000 U/ml IFN-␥ plus 100 ng/ml LPS for 72 h (iTHP-1) according to previously described methods (20) .
Immunoprecipitation. M-280 tosylactivated Dynabeads (2 ϫ 10 9 / ml), which ensure the correct orientation of antibody and have minimum nonspecific binding (supplemental Fig. S.1 ), were coated with anti-P2X7 mAb (clone L4) according to the manufacturer's instruction and kept at 4°C for no more than 30 days. THP-1 cells (2 ϫ 10 6 ) or HEK-293 cells (5 ϫ 10 6 ) were washed twice following pretreatment with ATP or other compounds, and resuspended in 180 l extraction buffer (750 mM ε-amino-n-caproic acid and 50 mM Bistris, pH 7.2) with 40 l Mini-complete Protease Inhibitor cocktail (stock: 2.0 ml extraction buffer/tablet) and 4 mM PMSF at 4°C, followed by addition of 20 l 10% n-dodecyl ␤-D-maltoside, a mild nonionic detergent. The presence of high concentrations of ε-aminon-caproic acid enhances the solubility of membrane protein and helps to keep an intact complex (37) . Cells were allowed to lyse for 30 min at 4°C, 200 l of extraction buffer was added and centrifuged at 20,000 g for 15 min, and the supernatant was collected. Supernatants were preincubated with either WMD7-coated or sheep anti-mouse Ig polyclonal antibody-coated Dynabeads for 45 min at 4°C, and the beads were separated by magnetic force. L4-coated Dynabeads (50 l for THP-1 or 200 l for HEK-293) were washed once and mixed with the supernatant and incubated at 4°C in a rotator for 4 h. The Dynabeads were washed six times with PBS and stored at Ϫ30°C until the next day. The proteins on Dynabeads were eluted by boiling at 95°C for 5 min in Laemli sample loading buffer and separated on a 4 -20% gradient SDS-PAGE under reducing conditions. Proteins were transferred to nitrocellulose membrane and blocked overnight in TTBS buffer (20 mM Tris, 150 mM NaCl, and 0.05% Tween 20, pH 7.5) containing 5% skim milk powder. The membrane was washed and incubated with either a rabbit anti-NMMHC antibody (1:2,000), a mouse anti-NMMHC-IIA mAb (1:1,000), a rabbit anti-myosin Va antibody (1:500), a goat anti-Ro-52 (SSA1) antibody (1:1,000), or a sheep anti-human P2X7 antibody (1:1,000) in TTBS buffer for 2 h. The membrane was washed and incubated with horseradish peroxidase-conjugated secondary antibody (1:2,500) for 1 h, and the bands were detected with the SuperSignal kit.
Mass spectrum analysis. Immunoprecipitation was performed as described above except that 10 times more cells were used and PMSF Plus reagent (Roche), which prevents PMSF-induced protein modification, was added when the cells were being lysed. Proteins eluted from Dynabeads were separated on a 4ϳ20% SDS-PAGE (1 mm thick, 20 ϫ 20 cm) under reducing conditions. The gel was stained with Brilliant Blue G and destained. The band was cut and destained with 50 mM ammonium bicarbonate-50% acetonitrile and dried, followed by trypsin digestion. The samples were analyzed in a Voyage MALDI-TOF mass spectrometer. The peptide mass fingerprintings were then analyzed using PeptIdent (http://kr.expasy.org/).
Cloning of MYH9. Total RNA was extracted from iTHP-1 cells. Two pairs of primers were used to clone the MYH9 gene, which contains the coding region for NMMHC-IIA: forward [1] , 5Ј-CTG GCTAGC AGT CAC CAT GGC ACA GCA AGC-3Ј and reverse [1] , 5Ј-CTC CCG GAA G GAATTC TTC TCG TCC TC-3Ј; forward [2] , 5Ј-GAG GAC GAG AA GAATTC CTT CCG GGA G-3Ј and reverse [2] , 5Ј-CTA CCG GTG AAG AGG CTT TTT CGG CAG GTT TGGCCT CAG-3Ј. The RT-PCR was performed using the One-step RT-PCR Kit for Long Template (Invitrogen) according to the manufacture's instruction. Amplified RT-PCR products were purified using the GFX PCR DNA and Gel Band Purification Kit. The two products were inserted into a pDsRed-monomer-N1 vector between the NheI/ EcoRI sites, followed by a second insertion to the EcoRI/AgeI sites. The pDsRed-monomer-N1-MYH9 construct containing the complete cDNA coding for NMMHC-IIA was fully sequenced. The pAcGFP-N1-MYH9 was constructed by replacing the NheI/AgeI fragment with the one cut from pDsRed-monomer-N1-MYH9.
Transfection of HEK-293 cells. The total 10 g plasmid DNA or 1 g plain vector was incubated in serum-free Opti-MEM I medium Fluorescence lifetime imaging. HEK cells cotransfected with AcGFP or DsRed tagged P2X 7 and NMMHC-IIA were washed and kept in Na medium. Cells were visualized under a Nikon C1-LIMO confocal microscope with a life-time imaging module (LIMO). Fluorescence lifetime imaging (FLIM) is an accurate and reliable method to measure the FRET efficiency as no compensation is required for donor fluorophore emission recorded in the acceptor channel. Although the fluorescence lifetime is independent of the intensity of the fluorophores, high intensity of AcGFP and DsRed fluorescence is still required in live cell imaging to ensure enough measurements in real time. A ϫ60 water immersion objective lens (Nikon Plan Apo) and a DH-35i culture dish incubator with temperature control unit (Warner Instruments, Hamden, CT) were used. The 488-nm and 561-nm solid-state lasers were used for standard AcGFP and DsRed confocal imaging, respectively, and the picosecond-pulsed 440-nm laser and high-speed-gated detection system was used to measure the lifetime of AcGFP fluorescence. The images were captured and analyzed with the EZ-C1 software (Version 3.0). The FRET efficiency (E) and the molecular separation distance (r) were estimated according to the Förster formulas (15) as follows: E ϭ 1 Ϫ TdЈ/Td, where TdЈ and Td is the donor fluorophore lifetime in the presence and absence of acceptor, respectively. E ϭ 1/[1 ϩ (r/R0) 6 ], where the Förster radius (R 0 ϭ 4.7 Ϯ 0.5 nm) for EGFP-DsRed pattern (32) is used for the estimation.
Live cell imaging. HEK cells cotransfected with AcGFP or DsRedtagged P2X 7 and NMMHC-IIA were washed and kept in Na medium. Cells were visualized under a Olympus IX-81 inverted fluorescent microscope with filter sets including AcGFP: HQ470/40x, Q495LP, HQ525/50m; DsRed: HQ545/30x, Q570LP, HQ620/60m; FRET: HQ470/40x, Q495LP, HQ620/60m (exciter, dichroic, emitter) (Chroma Technology, Rockingham, VT). A ϫ40 objective lense and a DH-35i culture dish incubator with perfusion control and temperature control unit (Warner Instruments) were used. The images were captured and analyzed with the MetaMorph (version 6.0) software.
Time-resolved FRET flow cytometry. HEK cells cotransfected with pAcGFP-N1-MYH9 and pDsRed-monomer-N1-P2RX7 (1:4) were resuspended in Na medium with 0.1 mM CaCl 2 at a concentration of 2.0 ϫ 10 6 /ml. Cell suspensions were stirred and temperature was maintained at 37°C using a time 0 module, and after 2 min, ATP (1.0 mM) or BzATP (100 M) was added. Cells were analyzed at about 1,500 events/s on a FACSCalibur flow cytometer and were gated by forward and side scatter and by AcGFP and DsRed fluorescence intensity. The log mean channel of fluorescence intensity for each gated subpopulation over successive 5-s intervals was analyzed by WinMDI software and plotted against time.
siRNA blocking. To block P2X 7 and NMMHC-IIA at transcriptional level, siRNA was designed using online program from Invitrogen, siDirector, and Wistar. The sequences were as the followings: P2RX7 siRNA, 5Ј-cga ugg acu uca cag auu u-3Ј and 5Ј-aca ucc ugc cag guu uaa aTT-3Ј; MYH9 siRNA, 5Ј-cgu gcg ugc uca uga uaa a-3Ј and 5Ј-cca agc agc uga agg aca aTT-3Ј; control siRNA, 5Ј-cga cau acu gua cag gcc uTT-3Ј. The duplex of each siRNA were synthesized by Sigma-Proligo. The siRNA (50 M each for P2RX7, for MYH9 or 100 M for control) was mixed with 100 l HiPerFectin and added into 8 ml THP-1 cells (0.5 ϫ 10 6 /ml), which have been stimulated either with 100 nM PMA for 4 h or with 1,000 U/ml IFN␥ plus 100 ng/ml LPS for 48 h in OPTI-MEM medium with 5% FCS. Cells were kept in culture for another 48 h before collection for ethidium ϩ uptake and Western blotting.
shRNA blocking. Two shRNA vector sets each targeting five different sites of the human MYH9 and Myo5A genes were obtained from Sigma-Genosys. The pLKO.1-puro control vector was used as a control. HEK-293 cells were transfected with 10 g shRNA vector, and 2 days later the cells were transfected with 10 g of AcGFP-P2X 7 constructs with HEKFectin. Cells were cultured for an additional 44 h and collected for ethidium ϩ uptake and Western blotting. Electrophysiology. Patch-clamp recordings were performed at room temperature by using a HEKA EPC10 amplifier and Patchmas- Proteins were isolated from either interferon-␥ plus LPS-stimulated THP-1 cells or P2X7-transfected HEK-293 cells using L4-coated Dynabeads and analyzed by mass spectrometry. Cells were not pretreated with ATP before lysis and incubation with L4-Dynabeads. Only proteins identified in at least two separate experiments are included. The Swiss-Prot accession number, the calculated molecular mass of protein band from SDS-PAGE, and the overall highest PeptIdent score are listed. IFN-␥, interferon-␥ ; TPR, tumor potentiating region; InsP6, inositol hexakisphosphate; PP-IP5 kinase 1, diphosphoinositol-pentakisphosphate kinase 1; HSP, heat shock protein.
ter software. Membrane potential was clamped at Ϫ60 mV, and agonist (1 mM ATP) was applied using a computer-controlled fastflow system (Bio-Logic Instruments). Cells were plated onto 13-mm glass coverslips 24 h before recordings, which were performed 72 h posttransfection with human P2X 7-AcGFP and 96 h posttransfection with shRNA constructs. Standard external/internal pipette solutions were (in mM) 145 NaCl, 5 KCl, 2 CaCl 2, 1 MgCl2, 13 D-glucose, 10 HEPES (pH 7.3), and 145 NaCl, 10 HEPES, 10 EGTA (pH 7.3), 300 -310 mosmol/l, respectively. Pipettes were pulled from borosilicate glass using a Narashige PC-10 and resistance was 6 -8 M⍀.
Ethidium ϩ uptake. Human mononuclear cells (2 ϫ 10 6 ) prelabeled with FITC-conjugated anti-CD14 mAb or HEK-293 cells (2 ϫ 10 6 ) transfected with AcGFP tagged P2X7 receptor constructs were washed once and resuspended in 1.0 ml HEPES-buffered KCl medium at 37°C. All samples were stirred and temperature maintained at 37°C using a time 0 module. Ethidium ϩ (25 M) was added, followed 40 s later by addition of 1.0 mM ATP. Cells were analyzed at 1,000ϳ1,500 events/s on a FACSCalibur flow cytometer and were gated by forward and side scatter and by cell type-specific antibodies or AcGFP intensity. The linear mean channel of fluorescence intensity (0 -255 channel) for each gated subpopulation over successive 5-s intervals was analyzed by WinMDI software and plotted against time as described previously (19, 22) . The areas under ATP-induced ethidium uptake curves were also calculated at 5 and 2.5 min as described previously (22) (20) . The iTHP-1 cells were treated with or without ATP for 5-15 min, washed to remove ATP, and lysed. P2X 7 was separated using Dynabeads-coated with anti-P2X 7 monoclonal antibody (clone L4). Several proteins associated with P2X 7 were identified by mass spectrometry to be with a score greater than 0.3 ( Table 1 ). In cells not exposed to ATP the most significant one was a ϳ220-kDa protein of which its mass fingerprinting showed a high score of 0.95 of identity to NMMHC-IIA in iTHP-1 cells (Table 1, Fig. 1 ). The results were confirmed by Western blotting in which the P2X 7 -associated proteins were separated by gel electrophoresis and transferred to a nitrocellulose membrane. A 220-kDa band corresponding to the size of NMMHC-IIA (220 kDa molecular mass) was detected by a rabbit anti-nonmuscle myosin heavy chain polyclonal antibody in immunoprecipitates from iTHP-1 lysate (Fig. 1C) . In contrast, no band was found in immunoprecipitated proteins from cell lysate of unstimulated THP-1 (Fig. 1B) . Other proteins found in the immunoprecipitate were protein-tyrosine phosphatase, Ro52, ␤-actin, and myosin regulatory light chain (Table  1) . Our finding of ␤-actin and protein tyrosine phosphatase in the P2X 7 membrane complex is in line with previous data (24), although these authors did not report the presence of NMMHC-IIA, possibly because of differences in cell type.
Extracellular ATP dissociates the P2X 7 -NMMHC-IIA complex. To determine whether the complex was altered following P2X 7 activation, the THP-1 cells were pretreated with ATP before washing. Both SDS-PAGE gel and Western blotting images showed that pretreatment of cells with 1 mM ATP for 5-10 min caused a marked reduction of NMMHC in L4-Dynabeads isolated proteins from cell lysates of iTHP-1 (Fig.  1C) . In contrast, the protein amount of another immunoprecipitated protein, the Sjogren's syndrome type A antigen Ro-52, was found unchanged following ATP activation (Fig. 1C) . Other proteins that were unchanged in the immunoprecipitate include InsP6 and PP-IP5 kinase 1, protein-tyrosine phosphatase, and ␤-actin. KN-62, a potent P2X 7 antagonist (16), abolished ATP-induced dissociation of the P2X 7 -NMMHC complex in iTHP-1 cells (Fig. 1C) . KN-04, a weaker antagonist of P2X 7 , did not inhibit ATP-induced dissociation of NMMHC-IIA. These results suggest that activation of P2X 7 disrupts its cytoskeletal attachments in iTHP-1 cells.
P2X 7 membrane complex contains myosin Va in HEK-293 cells and is also dissociated by ATP.
A similar approach was adopted to examine the proteins of P2X 7 complex in HEK-293 cells transfected with P2X 7 constructs. The cells were treated with or without ATP for 10 min, washed, and lysed, and P2X 7 complex was pulled down using L4-Dynabeads. Of the seven proteins identified by mass spectrometry, only two with a score above 0.5 were the same as found in the complex from THP-1 cells (Table 1) . Myosin Va was found to be the predominant nonmuscle myosin heavy chain associated with P2X 7 in HEK-293 cells (Table 1) , although other nonmuscle myosin heavy chains, such as NMMHC-IIA and IIB, were present with lower scores (data not shown). Western blot analysis confirmed a ϳ220-kDa band corresponding to the size of myosin Va (215.6 kDa molecular mass) was present and detected by rabbit anti-nonmuscle myosin heavy chain polyclonal antibody (Fig. 2B) . In contrast, no band was found in immunoprecipitated proteins from mock transfected HEK-293 cell lysates. Other proteins found in the immunoprecipitate were Nucleoprotein tumor potentiating region (TPR), heat shock protein 90 and 70, Ro-52, tubulin, and nucleoside diphosphate kinase B (C-myc purine-binding transcription factor PUF) ( Table 1) . Our finding of heat shock protein 70 and 90 and tubulin in the P2X 7 membrane complex is in line with previous data (24) . Pretreatment of transfected HEK-293 cells with 1 mM ATP for 10 min dramatically reduced the amount of NMMHC associated with P2X 7 complex, shown by both SDS-PAGE and Western blotting (Fig. 2) . The P2X 7 constructs in different vectors, pCI (Promega), EGFP-N1 or EGFP-C1 (Clontech), gave similar results. In contrast, Ro-52, which was associated with P2X 7 in both THP-1 and HEK-293 immunoprecipitates, remained unchanged following exposure of cells to ATP (Fig. 2B) .
Colocalization of P2X 7 and NMMHC-IIA. The association between P2X 7 and NMMHC-IIA was further studied by cloning the MYH9 gene (gene encoding NMMHC-IIA) from THP-1 cells and tagging NMMHC-IIA COOH-terminus with fluorescent AcGFP or DsRed monomer, which is known to maintain a functional molecule (3, 45) . The use of monomeric form of AcGFP and DsRed reduces the possible false interaction caused by the fluorescent protein self-association. HEK-293 cells were cotransfected with NMMHC-IIA-DsRed and P2X 7 -AcGFP. The live cell confocal imaging showed that P2X 7 and NMMHC-IIA were colocalized in plasma membrane and membranes of intracellular organelles (Supplemental Fig.  S.2a) . It is well established that a major fraction of P2X 7 resides within intracellular membranes (19) , and it can be readily visualized in membranes surrounding intracellular organelles (Supplemental Fig. S.2a) . Blebbing of plasma membrane was induced by addition of BzATP to cotransfected HEK-293 cells. Fluorescent microscopy showed the presence of both P2X 7 and NMMHC-IIA in the cell blebs induced by agonist (Supplemental Fig. S.2b and videos) , suggesting that NMMHC-IIA was involved in the P2X 7 -mediated cell blebbing.
Fluorescence (FRET-FLIM) study proves close P2X 7 -NMMHC interaction in live cells.
Confocal microscopy is limited by optical resolution (200ϳ300 nm), and simple colocalization of these two molecules does not prove their direct interaction. The direct interaction between P2X 7 and NMMHC-IIA was studied in HEK-293 cells, which were cotransfected with NMMHC-IIA-AcGFP and P2X 7 -DsRed monomer. The FRETbased FLIM was used to measure the lifetime of AcGFP in colocalized regions. After excitation by a 440-nm pulse laser, the lifetime of AcGFP was 1.7 Ϯ 0.2 ns and increased to 4.3 Ϯ 0.3 ns after incubation with 100 M BzATP for 15 min (Fig.  3a) . In the cells cotransfected with pAcGFP-N1 and pDsRedmonomer-N1 empty vector, the lifetime of AcGFP remained at 4.2-4.5 ns after BzATP treatment (data not shown). FRET-FLIM in conjunction with confocal microscopy operates over a scale of 1ϳ10 nm and is a sensitive reporter of the close interaction between two molecules. Calculations from our data showed tight association of the two molecules with an interacting distance between the COOH-terminus of P2X 7 and COOH-terminus of NMMHC-IIA of ϳ4.4 nm and a calculated FRET efficiency of ϳ0.6. After 15 min incubation with BzATP the lifetime of AcGFP increased, indicating there was no interaction between P2X 7 and NMMHC-IIA.
To study the P2X 7 -NMMHC interaction in a large cohort of live cells, we developed a FRET-based time-resolved flow cytometry assay system. The protein interaction was assessed by monitoring the fluorescence intensity changes of AcGFP and DsRed in double-positive cells over several minutes. In HEK-293 cells cotransfected with NMMHC-IIA-AcGFP and P2X 7 -DsRed, ATP or BzATP led to a decrease of P2X 7 -DsRed fluorescent intensity in parallel with a slight increase of NMMHC-IIA-AcGFP intensity over a 15-min period in gated AcGFP ϩ /DsRed ϩ cells (Fig.  3B) . Pretreatment with KN-62 abolished the effect of ATP (Fig.  3B) . These data confirm the immunoprecipitation results and show that P2X 7 and NMMHC-IIA are tightly associated and that ATP is causing dissociation of P2X 7 from NMMHC-IIA.
Both NMMHC-IIA and myosin Va are limiting factors for P2X 7 pore formation. Channel to pore transition is also known as secondary pore formation, which occurs over 1 to 10 min following agonist activation and is a distinguishing feature of the P2X 7 receptor. We investigated the role of NMMHC-IIA and Myosin Va in P2X 7 -transfected HEK-293 cells. HEK-293 cells were pretransfected with shRNA producing vectors targeting on either MYH9 or Myo5A (the gene coding for myosin Va) before the transfection of P2X 7 -AcGFP. Reducing the expression of either NMMHC-IIA or myosin Va in P2X 7 -transfected HEK-293 cells significantly increased ATP-induced ethidium ϩ uptake (Fig. 4A) . The most significant results came from the HEK-293 cells in which both NMMHC-IIA and myosin Va were knocked down, and P2X 7 -mediated ethidium ϩ uptake was increased almost fourfold compared with the vector control (Fig. 4A) . In contrast to this large increase in P2X 7 pore permeability, the ATP-induced inward current was the same in control cells and cells transfected with shRNA against both nonmuscle myosin classes (Fig. 4B) . To further confirm that P2X 7 expression was unaltered by shRNA knockdown of nonmuscle myosins, we measured P2X 7 surface expression by flow cytometry and found it did not change (Fig. 4C) . Western analysis showed that the protein level of NMMHC in HEK-293 cells was reduced 20 -40% with single shRNA blocking and 50ϳ70% with double shRNA blocking (Fig. 4D) . Similar results were seen when siRNA targeted against MYH9 was transfected into iTHP-1 cells. The siRNA blocked 30 -50% expression of NMMHC-IIA (Fig. 5B) and enhanced the ATPinduced ethidium uptake compared with cells transfected with scrambled siRNA (Fig. 5A) . Control cells transfected with siRNA to P2X 7 showed both reduced P2X 7 protein and reduced ATP-induced ethidium ϩ influx (Fig. 5A) . Inhibition of NMMHC-IIA ATPase blocks P2X 7 pore formation. Since NMMHC-IIA directly interacts with P2X 7 , the effect of the specific NMMHC-IIA ATPase inhibitor S-bleb (42) and its inactive isomer R-bleb were studied on pore formation. ATP-induced ethidium ϩ uptake in fresh isolated human monocytes was reduced significantly by pretreatment of 100 M S-bleb for 1 h but not by R-bleb (Fig. 6B) . In parallel experiments, S-bleb but not R-bleb inhibited the ATP-induced dissociation of NMMHC from the P2X 7 complex in iTHP-1 cells (Fig. 6A) . These results suggest dissociation of P2X 7 from NMMHC-IIA may be required for P2X 7 pore dilatation, and the dissociation requires ATP hydrolysis. 7 pore formation. NMMHC-IIA is known to interact with Factin, thus we examined the effect of depolymerizing F-actin on P2X 7 pore formation. HEK-293 cells transfected with P2X 7 -AcGFP were pretreated with or without 20 M cytochalasin D or 1 M latrunculin A, two potent classical inhibitors for F-actin polymerization. Both cytochalasin D and latrunculin A had no effect on ATP-induced ethidium ϩ uptake (Supplemental Fig. S.3 ), suggesting that F-actin was not involved in P2X 7 pore formation.
Inhibition of F-actin polymerization does not affect P2X

DISCUSSION
Our novel finding of a close molecular interaction between P2X 7 and nonmuscle myosin and its dissociation by extracellular ATP provides insight into the possible mechanisms by which the P2X 7 channel dilates to a larger pore. It is known that P2X 7 forms part of a multiprotein complex (24) , and our initial results showed this complex included nonmuscle myosin, although the nonmuscle myosin was class IIA in monocytic cells and class Va in HEK-293 cells. Anchoring of P2X 7 on the membrane by its tight molecular attachment to NMMHC has not been previously described, although the effect of ATP to rearrange the actin cytoskeleton is well described (33) . A number of previous studies have demonstrated membrane blebbing induced by activation of P2X 7 (33, 50, 51) , and it is likely the dissociation of nonmuscle myosin from P2X 7 releases this receptor from cytoskeletal tethering and allows ATP-induced blebbing (see supplementary videos).
Previous studies have shown many different proteins associated with the P2X 7 receptor complex (4, 12, 24) . Thus the differences in methodology, e.g., type of cells, lysing method and immunoprecipitation matrix, may result in differences in the coassociated proteins. We used both native monocytemacrophage cell line THP-1 and P2X 7 -transfected HEK-293 cells to extract the P2X 7 complex for analysis. Besides myosin IIA and myosin Va, two important components of the cytoskeleton, actin and tubulin, were also found in the complex, supporting the data above showing attachment of P2X 7 to the underlying cytoskeleton. Our finding of protein tyrosine phosphatase in the P2X 7 membrane complex is in line with the data of Kim et al. (24) as also was the finding of two chaperone proteins, heat shock protein 70 and 90. Nuclear membrane protein TPR was found only in P2X7-transfected HEK-293 cells and is a component of the nuclear pore complex. It is involved in activation of oncogenic kinases (6) , and its long coiled-coil COOH-terminus (over 1,600 amino acids) facilitates export of mRNA and other macromolecules from the nucleus (2) . The association of TPR with P2X 7 in HEK-293 cells raises the possibility that P2X 7 may also be present in nuclear membrane. Interestingly, the Sjogren's syndrome type A antigen Ro-52 (also known as SS-A or TRIM21) is found in the P2X 7 complex in both THP-1 and HEK-293 cells, and this associated protein level did not change following activation of P2X 7 by ATP (Figs. 1 and 2 ). Ro-52 is a RING-finger-type E3 ubiquitin ligase catalyzing ubiquitination of substrate (11, 52) . The consistent association of P2X 7 and Ro-52 may be relevant to the finding of autoantibodies against Ro-52 in Sjogrens syndrome in which there is inflammatory destruction of salivary glands, a tissue with particularly high content of P2X 7 receptor (47) .
The interaction between P2X 7 and NMMHC-IIA was studied by using FLIM-FRET. In this study, the AcGFP lifetime of 1.7 ns increased to 4.3 ns following the addition of BzATP to cotransfected HEK-293 cells. This latter value is the same as that found for AcGFP lifetime in cells transfected with empty plasmid vectors. These data provide strong evidence for a close molecular interaction over ϳ4.4 nm between AcGFP-tagged NMMHC-IIA and DsRed-tagged P2X 7 with dissociation of these two molecules following activation of P2X 7 . To confirm the interaction of P2X 7 and NMMHC-IIA in a large cohort of cells, a FRET-based time-resolved flow cytometry method was also developed. With careful compensation settings, the AcGFP and DsRed emissions can be readily studied in a real-time flow cytometry system using only a 488-nm laser. The decreased DsRed fluorescence intensity over a 15-min period following the addition of ATP also indicated the dissociation of P2X 7 and NMMHC-IIA following P2X 7 activation by ATP. Our live cell confocal imaging also showed that P2X 7 and NMMHC-IIA were colocalized in apparent clusters not only in plasma membrane but also clustered at a limited number of locations in the cytoplasm (supplemental Fig. S.4) . This finding supports the recent demonstration of P2X 7 receptor in phagosome membranes of J-774 macrophages, which have taken up latex beads (26) .
The mechanism of channel dilatation (or pore formation) following ATP activation of P2X 7 is currently controversial. Our novel finding of a close molecular interaction between P2X 7 and NMMHC-IIA and its dissociation by extracellular ATP provides insight into the possible mechanisms by which the P2X 7 channel dilates to a larger pore. From this study, we propose that the P2X 7 receptor is anchored in the membrane by nonmuscle myosin in the absence of ligand. Indeed some nonmuscle myosin are thought to function as both transporters and anchors (1) . Once extracellular ATP reaches high concentrations, P2X 7 changes its conformation to open the intrinsic ion channel and the downstream effects, e.g., ionic shifts, allow a slow detachment of nonmuscle myosin from P2X 7 . Dissociation of P2X 7 from its cytoskeletal attachments may allow pore formation by P2X 7 , possibly by interaction with pore-forming proteins such as pannexin 1 (30) . Regulation of P2X 7 channel to pore transition is supported by the following observations. First, P2X 7 is complexed with nonmuscle myosin in the absence of ATP. Second, ATP dissociates P2X 7 -nonmuscle myosin complex in 1-10 min, which is in line with the time frame for ATP to induce pore formation (0.5-5 min). Third, decrease of expression of NMMHC-IIA in iTHP-1 cells or transfected HEK-293 cells significantly increased ATP-induced ethidium ϩ uptake without affecting the P2X 7 channel function, suggesting that decreasing the amount of nonmuscle myosin in the cytoskeleton facilitates the transition of P2X 7 channel to a pore. Fourth, as a specific inhibitor of NMMHC-IIA ATPase, S-Bleb not only reduced ATP-induced ethidium ϩ uptake in human monocytes but also inhibited ATP-induced dissociation of P2X 7 and nonmuscle myosin. In contrast, its inactive isomer R-bleb affected neither the function nor the dissociation in human monocytic cells, also suggesting that dissociation of P2X 7 -NMMHC-IIA complex is required for P2X 7 pore formation. In contrast, F-actin, which is well known to associate with NMMHC, appears to play no role in the P2X 7 pore formation since inhibition of actin polymerization by either cytochalasin D or latrunculin A did not alter ATP-induced ethidium ϩ uptake. Whatever the molecular nature of the P2X 7 large pore, it is likely that dissociation of P2X 7 from nonmuscle myosin of the cytoskeleton is a critical early step in the P2X 7 permeability transition.
